Neuromuscular blockade management in patients with COVID-19

Neuromuscular blockade management in patients with COVID-19

This narrative review evaluates the evidence for using neuromuscular blocking agents (NMBA) in patients being treated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While large prospective randomized-controlled trials (RCTs) are lacking at this point in time, smaller observational...

Full description

Bibliographic Details
Main Authors:	Harold Chaves-Cardona, Vivian Hernandez-Torres, Sean Kiley, Johnathan Renew
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2021-08-01
Series:	Korean Journal of Anesthesiology
Subjects:	covid-19 neuromuscular blockade neuromuscular blocking agents neuromuscular monitoring respiratory distress syndrome sars-cov-2
Online Access:	http://ekja.org/upload/pdf/kja-21106.pdf

Similar Items

A surgeon′s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
by: James J Lamberg, et al.
Published: (2013-01-01)

Neuromuscular blockade management in the critically Ill patient
by: J. Ross Renew, et al.
Published: (2020-05-01)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
by: Gonzalo Domenech, et al.
Published: (2019-08-01)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
by: Tom Schepens, et al.
Published: (2019-10-01)

MONITORING OF VARIOUS TYPES OF NEUROMUSCULAR BLOCKADE
by: N. V. Chubchenko, et al.
Published: (2018-01-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study
by: Faraj K Alenezi, et al.
Published: (2021-05-01)

A multicenter survey on the use of neuromuscular blockade in Greece. Does the real-world clinical practice indicate the necessity of guidelines?
by: Chrysanthi Batistaki, et al.
Published: (2019-01-01)

Effect of pneumoperitoneum on the recovery from intense neuromuscular blockade by rocuronium in healthy patients undergoing laparoscopic surgery
by: Hong Soon Kim, et al.
Published: (2014-07-01)

THE RISK ASSESSMENT OF THE RESIDUAL NEUROMUSCULAR BLOCKADE UNDER LAPAROSCOPIC OPERATIVE INTERVENTIONS
by: D. A. Kurenkov, et al.
Published: (2017-11-01)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
by: Yong Beom Kim, et al.
Published: (2021-08-01)

Functional recovery following neuromuscular blockade in critically ill adults
by: Foster, Janet G. Whetstone, 1953-
Published: (2011)

Neuromuscular diseases and anesthesia
by: Antonijević Vesna, et al.
Published: (2018-01-01)

Comparison of Operating Conditions, Postoperative Pain and Recovery, and Overall Satisfaction of Surgeons with Deep vs. No Neuromuscular Blockade for Spinal Surgery under General Anesthesia: A Prospective Randomized Controlled Trial
by: Seok Kyeong Oh, et al.
Published: (2019-04-01)

The effect of hand dominance on neuromuscular monitoring at the adductor pollicis muscle
by: Ji Seon Jeong, et al.
Published: (2013-07-01)

Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
by: An Thi Nhat Ho, et al.
Published: (2020-01-01)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
by: Khawaja Rashid Hafeez, et al.
Published: (2018-07-01)

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
by: Carron M, et al.
Published: (2016-02-01)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
by: Ji Hyeon Lee, et al.
Published: (2012-05-01)

Neuromuscular blockade is associated with the attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome
by: Peter D. Sottile, et al.
Published: (2018-03-01)

Neuromuscular block in patients 80 years and older: a prospective, controlled study
by: Denis Schmartz, et al.
Published: (2021-09-01)

Neuromuscular blockade in cardiac surgery: An update for clinicians
by: Hemmerling Thomas, et al.
Published: (2008-01-01)

Analysis of Clinical Indicators of Quality in Patients with Endotracheal intubation
by: Sulochana Dash, et al.
Published: (2017-06-01)

Comparison of Train of Four Measurements with Kinemyography NMT DATEX and Accelerography TOFscan
by: Cyrus Motamed, et al.
Published: (2021-03-01)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
by: Carron M, et al.
Published: (2017-12-01)

The tof-guard neuromuscular transmission monitor and its use in horses O monitor da transmissão neuromuscular "tof-guard" e seu uso em eqüinos
by: Juliana Noda Bechara, et al.
Published: (1999-03-01)

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
by: Usha Gurunathan, et al.
Published: (2019-11-01)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01)

Postoperative residual block in postanesthesia care unit more than two hours after the administration of a single intubating dose of atracuriumFNx01
by: Mojtaba Rahimi Varposhti, et al.
Published: (2011-01-01)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01)

Analysis of incidence of residue neuromuscular blockade for rocuronium and cisatracurium
by: Qing-Long Dong
Published: (2020-11-01)

The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade
by: Won Ji Rhee, et al.
Published: (2015-02-01)

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
by: Chen, L., et al.
Published: (2022)

Comparison of deep or moderate neuromuscular blockade for thoracoscopic lobectomy: a randomized controlled trial
by: Xiao-feng Zhang, et al.
Published: (2018-12-01)

Sugammadex: clinical development and practical use
by: Thomas Fuchs-Buder, et al.
Published: (2013-12-01)

Phenobarbital influence on neuromuscular block produced by rocuronium in rats Influência do fenobarbital no bloqueio neuromuscular produzido pelo rocurônio em ratos
by: Angélica de Fátima de Assunção Braga, et al.
Published: (2008-08-01)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
by: Wei Chang, et al.
Published: (2020-02-01)

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
by: Hans D de Boer, et al.
Published: (2018-11-01)

Preparing for the unexpected: special considerations and complications after sugammadex administration
by: Hajime Iwasaki, et al.
Published: (2017-10-01)

The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade
by: Ji Hyeon Lee, et al.
Published: (2013-02-01)